NYSE Euronext Announces Trading Volumes for December 2012 – Mixed Results

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for December 2012[1]. Global derivatives

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for December 2012[1]. Global derivatives average daily volume (“ADV”) of 7.5 million contracts in December 2012 was down slightly compared to December 2011 and decreased 8.0% from November 2012 levels on seasonally slower trading activity. European derivatives fixed income ADV, however, increased 17.4% from December 2011 levels. Trading volumes in European and U.S. equities declined both year-over-year and month-over-month.

Highlights

Join the iFX EXPO Asia and discover your gateway to the Asian Markets

NYSE Euronext global derivatives ADV in December 2012 of 7.5 million contracts decreased 0.2% compared to December 2011 and decreased 8.0% from November 2012 levels.

NYSE Euronext European derivatives products ADV in December 2012 of 3.5 million contracts increased 1.5% compared to December 2011, but decreased 12.4% from November 2012 levels. Excluding Bclear, NYSE Liffe’s trade administration and clearing service for OTC products, European derivatives products ADV increased 8.5% compared to December 2011and increased 1.5% from November 2012.

NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 3.9 million contracts in December 2012 decreased 1.2% compared to December 2011 levels, and decreased by 4.4% from November 2012 levels. NYSE Euronext’s U.S. options exchanges accounted for 27.2% of total U.S. consolidated equity options trading in December 2012, down from 27.7% in December 2011 and down from 28.1% in November 2012.

NYSE Liffe U.S. ADV of approximately 72,600 contracts decreased from 89,600 contracts in December 2011, but increased from 51,500 contracts in November 2012.

NYSE Euronext European cash products ADV of 1.1 million transactions in December 2012 decreased 20.2% compared to December 2011 and decreased 8.7% compared to November 2012.

NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE-MKT) handled ADV of 1.5 billion shares in December 2012 decreased 14.7% compared to December 2011 and decreased 3.4% compared to November 2012. NYSE Euronext’s Tape A matched market share in December 2012 was 31.9%, down from 33.4% in December 2011, but up from 31.7% in November 2012.

The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the fourth quarter of 2012 is included below:

Derivatives Trading

European Derivatives

NYSE Euronext European derivatives products ADV in December 2012 was 3.5 million futures and options contracts, an increase of 1.5% from December 2011, but a decrease of 12.4% from November 2012.

The 3.5 million in European derivatives futures and options contracts ADV in December 2012 consisted of 2.4 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.1 million contracts, or 31.6%, executed through Bclear, NYSE Liffe’s trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV increased 8.5% compared to December 2011 and increased 1.5% from November 2012.

In the fourth quarter of 2012, European derivatives products ADV of 3.5 million contracts was 2.3% below prior year levels. The 3.5 million in futures and options contracts ADV in the fourth quarter of 2012 consisted of 2.3 million contracts executed through LIFFE CONNECT trading platform and 1.2 million contracts, or 33.7%, executed through Bclear.

For the full-year 2012, European derivatives products ADV of 3.7 million contracts was 16.8% below prior year levels. The 3.7 million in futures and options contracts ADV year-to-date consisted of 2.6 million contracts executed through LIFFE CONNECT trading platform and 1.1 million contracts, or 29.7%, executed through Bclear.

Total fixed income products ADV of 1.6 million contracts in December 2012 increased 17.4% from December 2011 and increased 0.3% from November 2012. In the fourth quarter of 2012, total fixed income products ADV of 1.6 million contracts was 13.3% below prior year levels. For the full-year 2012, total fixed income products ADV of 1.8 million contracts was 22.0% below prior year levels.

Total equity products (including Bclear) ADV of 1.8 million contracts in December 2012 decreased 10.6% compared to December 2011 and decreased 21.9% from November 2012. The 1.8 million contracts in equity products ADV consisted of 1.3 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.3 million contracts in individual equity products ADV consisted of 0.9 million in futures contracts, which represented a 14.0% decrease compared to December 2011 and 0.4 million in options contracts, which represented a 17.9% decrease compared to December 2011. In the fourth quarter of 2012, total equity products ADV of 1.9 million contracts were 7.6% below prior year levels. For the full-year 2012, total equity products ADV of 1.9 million contracts were 12.3% below prior year levels.

Total commodities products ADV of 97,000 contracts in December 2012 increased 43.3% compared to December 2011 and increased 12.5% compared to November 2012. In the fourth quarter of 2012, total commodities product ADV of 96,500 contracts was 34.3% above prior year levels. For the full-year 2012, total commodities product ADV of 89,000 contracts was 10.6% above prior year levels.

U.S. Derivatives

Suggested articles

Going Past the Great Wall: Things to Consider When Entering the Asian MarketGo to article >>

NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 3.9 million contracts in December 2012 decreased 1.2% compared to December 2011 and decreased 4.4% compared to November 2012. In the fourth quarter of 2012, U.S. equity options ADV of 4.0 million contracts was 6.7% below prior year levels. For the full-year 2012, U.S. equity options ADV of 3.9 million contracts was 11.6% below prior year levels.

Total U.S. consolidated equity options ADV increased 0.4% to 14.3 million contracts in December 2012 compared to December 2011, but decreased 1.5% compared to November 2012. In the fourth quarter of 2012, U.S. consolidated equity options ADV of 14.3 million contracts was 7.6% below prior year levels. For the full-year 2012, U.S. consolidated equity options ADV of 14.7 million contracts was 12.2% below prior year levels.

NYSE Euronext’s U.S. options exchanges accounted for 27.2% of the total U.S. consolidated equity options trading in December 2012, down from 27.7% in December 2011 and down slightly from a record 28.1% in November 2012.

NYSE Liffe U.S. ADV of approximately 72,600 contracts decreased from 89,600 contracts in December 2011, but increased from 51,500 contracts in November 2012. In December 2012, the mini MSCI Index futures traded a record ADV of 41,570 contracts, an increase of 108% compared to December 2011, and open interest across the entire MSCI complex hit an all time high on December 19, 2012 of 267,932 contracts. In the fourth quarter of 2012, U.S. futures and futures options ADV of 55,200 contracts was 39.4% below prior year levels. For the full-year 2012, U.S. futures and futures options ADV of 72,700 contracts was 10.4% below prior year levels.

Cash Trading

European Cash

NYSE Euronext European cash products ADV of 1.1 million transactions in December 2012 decreased 20.2% compared to December 2011 and decreased 8.7% compared to November 2012.

NYSE Euronext market share in European Cash products in December 2012 was 68.7%, up from 66.0% in December 2011 and up from 64.9% in November 2012.

In the fourth quarter of 2012, European cash products market share was 66.5% with ADV of 1.2 million transactions which was 25.6% below prior year levels.

For the full-year 2012, European cash products market share was 66.2% with ADV of 1.4 million transactions which was 15.5% below prior year levels.

U.S. Cash

NYSE Euronext U.S. cash products handled ADV in December 2012 decreased 14.7% to 1.5 billion shares compared to December 2011 and decreased 3.4% from November 2012.

In the fourth quarter of 2012, U.S. cash products handled ADV was 1.6 billion shares, down 27.3% from prior year levels.

For the full-year 2012, U.S. cash products handled ADV was 1.7 billion shares, down 26.2% from prior year levels.

NYSE Euronext’s Tape A matched market share in December 2012 was 31.9%, down from 33.4% in December 2011, but up from 31.7% in November 2012.

Exchange Traded Funds

NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 193 million shares in December 2012 decreased 22.1% compared to December 2011 and decreased 7.5% compared to November 2012.

In the fourth quarter of 2012, NYSE Euronext U.S. matched exchange-traded funds ADV of 197 million shares was 38.9% below prior year levels.

For the full-year 2012, NYSE Euronext U.S. matched exchange-traded funds ADV of 211 million shares was 34.9% below prior year levels.

Got a news tip? Let Us Know